Evidence map›Paper›PMID 33723743›Full record

ArticleCell biology and toxicology2022

Dimethyl sulfoxide stimulates the AhR-Jdp2 axis to control ROS accumulation in mouse embryonic fibroblasts.

Kenly Wuputra, Ming-Ho Tsai, Kohsuke Kato, Ya-Han Yang, Jia-Bin Pan, Chia-Chen Ku, Michiya Noguchi, Shotaro Kishikawa, Koji Nakade, Hua-Ling Chen and 10 more

Abstract read
In one paragraph

Article in Cell biology and toxicology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Autologous cord bloodWorld journal of clinical pediatrics · 2025
    Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Kenly WuputraGraduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Ming-Ho TsaiGraduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Kohsuke KatoDepartment of Infection Biology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan.
Ya-Han YangCell Therapy and Research Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Jia-Bin PanGraduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chia-Chen KuGraduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Michiya NoguchiCell Engineering Division, RIKEN BioResource Research Center, Tsukuba, Japan.
Shotaro KishikawaGene Engineering Division, RIKEN BioResource Research Center, Tsukuba, Ibaraki, Japan.
Koji NakadeGene Engineering Division, RIKEN BioResource Research Center, Tsukuba, Ibaraki, Japan.
Hua-Ling ChenNational Institute of Environmental Health, National Health Research Institutes, Zhunan, Taiwan.
Chung-Jung LiuRegenerative Medicine and Cell Therapy Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.
Yukio NakamuraCell Engineering Division, RIKEN BioResource Research Center, Tsukuba, Japan.
Kung-Kai KuoCell Therapy and Research Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Ying-Chu LinSchool of Dentistry, Kaohsiung Medical University, Kaohsiung, Taiwan.
Te-Fu ChanDepartment of Obstetrics and Gynecology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Deng-Chyang WuRegenerative Medicine and Cell Therapy Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.
Ming-Feng HouDepartment of Obstetrics and Gynecology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Shau-Ku HuangNational Institute of Environmental Health, National Health Research Institutes, Zhunan, Taiwan. skhuang@nhri.edu.tw.
Chang-Shen LinGraduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. csl@kmu.edu.tw.ORCID 0000-0001-7415-2187
Kazunari K YokoyamaGraduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. kazu@kmu.edu.tw.ORCID 0000-0001-8508-7587

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aryl hydrocarbon receptor (AhR) is a ligand-binding protein that responds to environmental aromatic hydrocarbons and stimulates the transcription of downstream phase I enzyme-related genes by binding the cis element of dioxin-responsive elements (DREs)/xenobiotic-responsive elements. Dimethyl sulfoxide (DMSO) is a well-known organic solvent that is often used to dissolve phase I reagents in toxicology and oxidative stress research experiments. In the current study, we discovered that 0.1% DMSO significantly induced the activation of the AhR promoter via DREs and produced reactive oxygen species, which induced apoptosis in mouse embryonic fibroblasts (MEFs). Moreover, Jun dimerization protein 2 (Jdp2) was found to be required for activation of the AhR promoter in response to DMSO. Coimmunoprecipitation and chromatin immunoprecipitation studies demonstrated that the phase I-dependent transcription factors, AhR and the AhR nuclear translocator, and phase II-dependent transcription factors such as nuclear factor (erythroid-derived 2)-like 2 (Nrf2) integrated into DRE sites together with Jdp2 to form an activation complex to increase AhR promoter activity in response to DMSO in MEFs. Our findings provide evidence for the functional role of Jdp2 in controlling the AhR gene via Nrf2 and provide insights into how Jdp2 contributes to the regulation of ROS production and the cell spreading and apoptosis produced by the ligand DMSO in MEFs.

Indexed as

Polychlorinated DibenzodioxinsReceptors, Aryl HydrocarbonAnimalsDimethyl SulfoxideFibroblastsLigandsMiceNF-E2-Related Factor 2Reactive Oxygen SpeciesDimethyl SulfoxideLigandsNF-E2-Related Factor 2Polychlorinated DibenzodioxinsReactive Oxygen SpeciesReceptors, Aryl HydrocarbonAhRDimethyl sulfoxideJun dimerization protein 2Mouse embryonic fibroblastsNrf2Reactive oxygen species

Identifiers

PMID33723743
PMCPMC8986748

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.